Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02012374 · ClinicalTrials.gov registry record · NA

Overcoming Learned Non-Use in Chronic Aphasia

A NA study, sponsored by University of Massachusetts, Amherst.

Completed
Registry status
NA
Development phase
24
Enrollment target

NCT02012374 is a NA study that has completed, run by University of Massachusetts, Amherst. The registered enrollment target is 24 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02012374, a NA study, has completed, sponsored by University of Massachusetts, Amherst.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target

Study Summary

In this study the investigators are examining the effectiveness of intensive speech therapy in chronic moderate-to-severe stroke-induced aphasia under two conditions - responses "constrained" or unconstrained to speech. Both treatments involve massed practice communicating, using intensive language action therapy 3 hours/day, 5 days/week for two weeks, followed by six months of a home practice program. One treatment stresses spoken responses as the preferred expressive modality during intensive therapy. Before and after treatment, and following the home practice program and a period of no practice, the investigators will administer several tests and discourse samples to examine changes associated with the treatments. Participants will also undergo structural and functional MRI testing at these time points. The investigators will also attempt to quantify the degree to which improvements following intensive language therapy and home practice correlate with changes in Quality of Life measures as perceived by both participants with aphasia and their significant others. It is hypothesized that, whereas both treatments will lead to improvements in naming practiced words and communicating, outcomes will be enhanced for the group randomly assigned to the "constraint" condition. Moreover, performance will be enhanced on words practiced during the home practice program, including those that were not practiced during intensive therapy. Improved naming will correlate with modulation of 'signature' language and attentional networks, whose variability will depend on remaining viable brain structures. Initial severity and site/extent of lesion should predict patients' ability to transfer gains in naming to improvements in discourse.

Interventions

  • BEHAVIORAL Intensive Language Action Therapy

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2012-02-26
Est. Completion 2015-07-09
Phase NA

What the Registry Record Tells You About NCT02012374

The ClinicalTrials.gov registry entry for NCT02012374 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Amherst, which has 33 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Intensive Language Action Therapy is the first listed.

NCT02012374 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02012374 about?

NCT02012374 is a clinical study titled "Overcoming Learned Non-Use in Chronic Aphasia". In this study the investigators are examining the effectiveness of intensive speech therapy in chronic moderate-to-severe stroke-induced aphasia under two conditions - responses "constrained" or unconstrained to speech. Both treatments involve massed practice communicating, using intensive language ...

What is the current status of trial NCT02012374?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2012-02-26. Estimated completion is 2015-07-09.

What interventions are being tested in trial NCT02012374?

The interventions under investigation include: Intensive Language Action Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT02012374?

This trial is sponsored by University of Massachusetts, Amherst, which has 33 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.